Share class: Alliance Pharma plc

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A1540,565,539475,978,383 ( 88.05 %) 0 88.05 %

Major shareholders: Alliance Pharma plc

NameEquities%Valuation
DBAY Advisors Ltd.
26.21 %
141,696,240 26.21 % 81 M p
CACEIS Bank SA
11.03 %
59,636,000 11.03 % 34 M p
Slater Investments Ltd.
9.364 %
50,620,424 9.364 % 29 M p
Rathbones Investment Management Ltd.
4.804 %
25,968,567 4.804 % 15 M p
Glazer Capital LLC
4.634 %
25,049,332 4.634 % 14 M p
Fidelity Management & Research Co. LLC
3.634 %
19,644,025 3.634 % 11 M p
Sand Grove Capital Management LLP
3.297 %
17,823,784 3.297 % 10 M p
Artemis Investment Management LLP
3.066 %
16,576,144 3.066 % 9 M p
Alpine Associates Management, Inc.
2.79 %
15,080,639 2.79 % 9 M p
Van Lanschot Kempen Investment Management NV
2.778 %
15,019,017 2.778 % 9 M p
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional96.05%
Other18.02%
Individuals2.41%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom 80.09%
United States 15.51%
France 12.86%
Netherlands 2.95%
Individuals 2.41%
Germany 1.55%
Luxembourg 0.82%
Switzerland 0.12%
Finland 0.1%
Denmark 0.03%
Canada 0.02%
Italy 0.02%

Based on 1000 largest holdings

Logo Alliance Pharma plc
Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.
Employees
290
More about the company